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Autoreactive B cells significantly contribute to 
the morbidity and mortality associated with 
many autoimmune diseases (Manjarrez-Orduño 
et al., 2009). B cell tolerance is normally con-
trolled at several checkpoints in the BM and 
periphery (Goodnow, 2007). In the periphery, 
BCR- and BAFFR-dependent signals are re-
quired for the differentiation of immature tran-
sitional B cells into mature B cells and the 
continued  maintenance  of  mature  B  cells   
(Cancro, 2009). B cells that express BCRs with 
intermediate affinity for autoantigens are less 
competitive than nonautoreactive B cells for 
access to the survival niches in the spleen and 
are eliminated at the transitional T1 stage of 
development (Lesley et al., 2004; Thien et al., 
2004).  However,  in  the  presence  of  excess 
BAFF (also known as BLyS), autoreactive B cells 
can pass the T1 checkpoint and enter the mature 
B cell pool (Thien et al., 2004). Thus, the appro-
priate survival and selection of B cells in the 
periphery appears to be dependent on a dynamic 
integration of BAFFR and BCR signals.
Engagement of either the BCR or BAFFR 
alone is insufficient to maintain mature B cell 
survival  in  the  periphery  (Cancro,  2009),  as 
BCR signaling is required to sustain NF-B–
dependent BAFFR signaling (Stadanlick et al., 
2008). In addition to the NF-B–dependent 
cross talk between BAFFR and the BCR, both 
receptors can also activate PI3K (Fruman and 
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Survival of mature B cells is regulated by B cell receptor and BAFFR-dependent signals.  
We show that B cells from mice lacking the Gq subunit of trimeric G proteins (Gnaq/ mice) 
have an intrinsic survival advantage over normal B cells, even in the absence of BAFF. Gnaq/  
B cells develop normally in the bone marrow but inappropriately survive peripheral tolerance  
checkpoints, leading to the accumulation of transitional, marginal zone, and follicular B cells, 
many of which are autoreactive. Gnaq/ chimeric mice rapidly develop arthritis as well as other 
manifestations of systemic autoimmune disease. Importantly, we demonstrate that the develop-
ment of the autoreactive B cell compartment is the result of an intrinsic defect in Gnaq/  
B cells, resulting in the aberrant activation of the prosurvival factor Akt. Together, these data 
show for the first time that signaling through trimeric G proteins is critically important for 
maintaining control of peripheral B cell tolerance induction and repressing autoimmunity.
©  2010  Misra  et  al.  This  article  is  distributed  under  the  terms  of  an   
Attribution–Noncommercial–Share  Alike–No  Mirror  Sites  license  for  the  first 
six months after the publication date (see http://www.rupress.org/terms). After   
six months it is available under a Creative Commons License (Attribution– 
Noncommercial–Share Alike 3.0 Unported license, as described at http://creative-
commons.org/licenses/by-nc-sa/3.0/).
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RESULTS
Gq regulates peripheral B cell homeostasis
Our laboratory previously showed that Gq regulates the in vitro 
chemotaxis of BM-derived neutrophils and DCs (Shi et al., 
2007). Based on these data, we wanted to test whether Gq 
was also required for B cell migration. However, mice lacking 
Gq (Gnaq/ mice) are difficult to study as they are born 
runted and exhibit motor defects (Offermanns et al., 1997). 
Therefore, to analyze the role of Gq specifically in immune 
cells, we generated BM chimeric mice by reconstituting lethally 
irradiated C57BL/6J recipient mice with either C57BL/6 BM 
(WT chimeras) or Gnaq/ BM (Gnaq/ chimeras). To deter-
mine whether Gq expressed by hematopoietic cells was re-
quired for the positioning of B and T cells within lymphoid 
tissues, we examined the splenic architecture of Gnaq/ and 
WT chimeras. Using antibodies (Abs) to B220, CD21, and 
CD90.2 (Thy1.2) we identified B220+ B follicles containing 
CD21+ follicular DC networks and CD90.2+ T cell zones in 
the spleens of WT and Gnaq/ chimeras (Fig. 1 A). However, 
the numbers of CD21hi B cells within the splenic marginal 
zone (MZ) appeared to be increased in the Gnaq/ chimeras 
(Fig. 1 A). To address whether this alteration was a result of 
changes in the migratory potential of the Gnaq/ B cells, we 
performed chemotaxis assays using spleen cells from WT and 
Gnaq/ chimeras. We found that the Gnaq/ B cells migrated 
normally to CXCL13, CXCL12, CCL19, and S1P (Fig. 1 B). 
Furthermore, upon transfer of purified WT and Gnaq/  
B cells to intact hosts, we found that the Gnaq/ B cells mi-
grated to both the B cell follicle and MZ of the spleen (Fig. 1 C). 
Therefore, the expansion of the MZ in the Gnaq/ chimeras 
did not appear to be a result of overt changes in the migratory 
capacity of the Gnaq/ B cells.
Previous  experiments  indicated  that  Gi-containing   
G proteins regulate BCR signaling, B cell activation, and parti-
tioning of B cells between the follicular and MZB cell subsets 
(Dalwadi et al., 2003). We therefore tested whether Gq, like 
Gi, regulates B cell development or maturation in the BM of 
chimeric mice (Fig. S1 A). We found that the total numbers 
of B220+ B cells in the BM of both groups of chimeras were 
equivalent (Fig. 1 D). Likewise, the absolute numbers of pro–B, 
pre–B (large and small), and immature B cells were indistin-
guishable between WT and Gnaq/ chimeras (Fig. 1 D).
Next, we examined peripheral B cell development using 
CD93, IgM, and CD23 to identify the T1, T2, and T3 subsets 
in the spleens of Gnaq/ and WT chimeras (Fig. S1 B). We 
found no differences between the numbers of T2 and T3 cells 
in the spleens of Gnaq/ and WT chimeras (Fig. 1 E).   
However, we reproducibly observed an increase in the per-
centage (Fig. S1 B) and number (Fig. 1 E) of T1 cells in the 
spleens of Gnaq/ chimeras. Interestingly, the percentages   
(Fig. S1 C) and  absolute  numbers  (Fig.  1  E)  of  CD19+ 
splenic B cells, CD19+CD21hiCD23lo MZ B cells (MZBs), 
and  CD19+CD21loCD23hi  follicular  B  cells  (FOBs)  were 
higher in the Gnaq/ chimeras compared with WT chimeras. 
Likewise, the percentage of CD21hi B cells expressing the 
MZB cell marker CD1dhi was also significantly elevated in 
Bismuth, 2009) and its downstream target Akt (Pogue et al., 
2000; Patke et al., 2006), a serine threonine kinase which 
functions as a prosurvival factor in many cell types (Manning 
and Cantley, 2007). One recent study showed that BCR- 
dependent survival of mature B cells is highly dependent on 
PI3K (Srinivasan et al., 2009), and another study showed that 
activation of the PI3K pathway can rescue normally anergic 
autoreactive B cells (Browne et al., 2009). The PI3K–Akt 
signaling pathway is also engaged by activation of seven   
transmembrane-spanning  G  protein–coupled  receptors 
(GPCRs; Yanamadala et al., 2009). GPCRs associate with het-
erotrimeric G proteins in their GDP-bound state (Wettschureck 
et al., 2004). Upon ligand binding to the GPCR, GDP is ex-
changed for GTP, which causes G protein release and the 
disassociation of the GTP-bound  subunit and the  dimer. 
Signal transduction is mediated by both the GTP-bound   
 subunit and the  dimer, but specialization and diversifica-
tion of the response is often mediated by the GTP-bound   
 subunits (Wettschureck et al., 2004). There are 16  subunits 
that fall into four classes, Gi, Gs, Gq/11, and G12/13, based on 
their downstream signaling targets. PI3K can be activated by the 
 dimers released from Gi-coupled receptors (Wettschureck 
et al., 2004). In contrast, Gq, a member of the Gq/11 family, 
normally inhibits PI3K activation and prevents activation of 
Akt (Harris et al., 2006). In cardiomyocytes, Akt activation 
and  cell  survival  is  enhanced  when  the  amount  of  active 
GTP-bound Gq is low (Howes et al., 2006). However, when 
the amount of active Gq is increased in cardiomyocytes, Akt 
activity is inhibited (Ballou et al., 2003) and survival of the 
cells upon stimulation is reduced (Howes et al., 2003). Exami-
nation of cardiomyocytes from transgenic mice expressing 
Gq in the cardiomyocytes indicated that the level of cardio-
myocyte apoptosis correlated directly with the amount of   
active Gq expressed in the cells (Adams et al., 1998). Likewise, 
increased expression levels of Gq are associated with changes 
in cardiomyocyte survival and in the development of cardiac 
disease in patients (Liggett et al., 2007; Frey et al., 2008). To-
gether, these data suggest that one major function of Gq is to 
suppress the PI3K/Akt signaling axis and cell survival. Sur-
prisingly, despite that fact Gq is expressed ubiquitously in   
B cells and myeloid cells (Wilkie et al., 1991), nothing is known 
regarding the requirement for Gq-containing G proteins in 
regulating Akt activity or hematopoietic cell survival.
In this paper, we show that Gq regulates peripheral B cell 
tolerance by suppressing the survival and selection of auto-
reactive B cells. In the absence of Gq, B cells constitutively 
express higher levels of activated Akt and preferentially sur-
vive BCR-induced cell death signals and BAFF withdrawal 
in vitro and in vivo. Most importantly, Gq-deficient mice rapidly 
develop an autoreactive B cell repertoire and systemic auto-
immunity. Together, these data show that Gq-containing   
G proteins, working in concert with the BCR and BAFFR 
signaling networks, regulate B cell development and periph-
eral tolerance induction. In addition, the data provide the 
first example of G protein–dependent suppression of B cell–
mediated autoimmunity.JEM VOL. 207, August 2, 2010 
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Interestingly, both the frequency (Fig. S1 G) and total num-
ber (Fig. 1 F) of the T1-derived MZB precursors were 
significantly elevated in the spleens of Gnaq/ chimeras. 
Collectively, the data suggest that Gq is not required for   
B cell development in the BM. However, Gq does modulate 
peripheral B cell development and appears to control the 
numbers of T1 cells, T1-derived MZB cell precursors, and 
mature MZB and FOB cells.
Gq regulates B cell survival in vitro
Given the alterations in splenic B cell homeostasis in Gnaq/ 
chimeras, we hypothesized that Gq may regulate B cell   
expansion or survival. To test this hypothesis, we cultured 
splenic WT and Gnaq/ B cells in media alone or with   
the spleens of Gnaq/ chimeras (Fig. S1 D). However, incon-
sistent with the phenotype of conventional MZB cells, 50% of 
the CD21hiCD23lo MZ-like B cells found in the spleens of the 
Gnaq/ chimeras also expressed high levels of IgD (Fig. S1 E).
To determine whether the expansion of MZ-like B cells 
in the Gnaq/ chimera spleens was the result of changes   
in the number of MZB precursors, we first examined the 
B220+CD93CD23hiCD21hi MZB cell precursors that are 
thought to arise from the T2 or FOII population (Srivastava 
et al., 2005; Cariappa et al., 2007). We found no difference 
between the percentages (Fig. S1 F) or numbers (Fig. 1 F) of 
these cells in spleens of Gnaq/ and WT chimeras. We next 
examined the MZB precursors (B220+CD93+CD23IgMhi 
CD21hi) found in the T1 population (Carey et al., 2008).   
Figure 1.  Altered B cell homeostasis in Gq-deficient chimeras. (A) Frozen sections of WT and Gnaq/ BM chimera spleens were stained with anti-CD90.2 
to identify T cell zones (blue), anti-B220 to identify B cell follicles (green), and anti-CD21 (red) to identify follicular DC networks in the B cell follicle and CD21hi B cells 
within the MZ. (B) Total B cells were isolated from WT and Gnaq/ chimera spleens and analyzed in in vitro chemotaxis assays using 300 ng/ml CXCL12, 500 ng/ml 
CXCL13, 400 ng/ml CCL19, or 10 nM S1P as chemoattractants. Data are presented as the mean ± SD of triplicate wells. (C) Splenic B cells from CD45.1+ WT and 
CD45.2+ Gnaq/ chimeras were purified. WT B cells were labeled with biotin and equivalent numbers of WT and Gnaq/ B cells were transferred into CD45.1+ 
hosts. Frozen sections were prepared from spleens 18 h after transfer and stained with SA-488 to visualize the transferred WT B cells (green), anti-CD45.2 to visual-
ize transferred Gnaq/ B cells (red), and anti–MOMA-1 (blue) to visualize the MZ. Bars, 50 µm. (D–F) BM and spleens were harvested from Gnaq/ and WT chime-
ras, stained with the indicated Abs to identify B cell subsets, and then analyzed by flow cytometry. (D) The absolute numbers of total BM B cells, pro–B, pre–B (large 
and small), and immature B cells were determined. (E) The numbers of T1, T2, and T3 transitional B cells and the numbers of total splenic B cells, FOB cells, and MZB 
cells were determined. (F) The numbers of splenic T2/FOII MZB precursors and T1 MZB precursors were determined. Data shown are the mean ± SD of five mice/group.   
P-values were determined using an unpaired Student’s t test. Data in all panels are representative of three or more independent experiments.1778 Gq suppresses B cell–mediated autoimmunity | Misra et al.
survive in vitro in higher numbers than WT B cells at all stages 
of transitional and mature B cell development.
Increased activation of BCR-mediated signaling  
in Gnaq/ B cells
GTP-bound Gq is reported to suppress activation of PI3K and 
Akt in nonhematopoietic cells (Bommakanti et al., 2000;   
Ballou et al., 2003). Given the enhanced in vitro survival of 
Gnaq/ B cells, we next tested whether the loss of Gq leads 
to enhanced Akt activation in B cells. We purified splenic   
B cells from WT and Gnaq/ chimeras, stimulated the cells 
with anti-IgM F(ab)2 for 0–30 min, prepared total protein ly-
sates, and performed Western blot analysis. We found that the 
basal levels of phospho-Akt (p-Ser473) were higher in Gnaq/ 
B cells than in WT B cells (Fig. 3 A). Furthermore, upon anti-
IgM stimulation phospho-Akt levels increased more rapidly in 
Gnaq/ B cells (Fig. 3 A), and the peak amount of phospho-
Akt was higher in the anti-IgM–stimulated Gnaq/ B cells 
than in the anti-Ig–stimulated WT B cells (Fig. 3 B). We also 
found that the levels of phosphorylated PLC2 (Y759) and   
Erk were significantly increased in the anti-IgM–stimulated 
Gnaq/ B cells relative to the WT B cells (Fig. 3, A and C). 
Consistent with these results, we noted that several protein 
species were hyperphosphorylated on either tyrosine (Fig. S2 A) 
or serine (Fig. S2 B) in the unstimulated Gnaq/ B cells rela-
tive to the WT B cells and were further phosphorylated as early 
as 1 min after anti-IgM stimulation. Thus, several signaling sub-
strates, including Akt, are hyperphosphorylated in Gnaq/  
B cells both before and after BCR ligation.
To address whether the increased Akt phosphorylation 
observed in the anti-IgM–stimulated splenic Gnaq/ B cells 
increasing amounts of anti-IgM F(ab)2 for 48 h, pulsed the 
cells with 3H-thymidine for 5 h, and measured thymidine in-
corporation. No major differences in DNA replication were 
observed between unstimulated and anti-IgM–stimulated 
Gnaq/ and WT B cells (Fig. 2 A). Likewise, we did not ob-
serve any differences in DNA replication between Gnaq/ 
and WT B cells stimulated with agonistic anti-CD40 Abs   
(Fig. 2 B). However, Gnaq/ B cells did proliferate more 
strongly (30% increase) in response to LPS than their WT 
counterparts (Fig. 2 C), suggesting that either a higher pro-
portion of Gnaq/ B cells are responsive to LPS or that 
Gnaq/ B cells are hyperresponsive to TLR4 ligands.
Because the loss of Gq only modestly affected the in vitro 
proliferative responses of splenic B cells, we next examined 
whether Gq regulates B cell survival. We cultured purified 
WT or Gnaq/ B cells in media alone or with anti-IgM F(ab)2 
and monitored viability. Surprisingly, a larger fraction of 
Gnaq/ B cells remained viable in both unstimulated and anti-
IgM–stimulated cultures (Fig. 2 D), suggesting that Gq plays a 
role in regulating the in vitro survival of mature B cells. To   
address whether Gq also modulates immature B cell survival, 
we sort purified T1 B cells and T2/T3 B cells from the spleens 
of WT and Gnaq/ chimeras, cultured the cells in media alone   
or with anti-IgM F(ab)2 for 18 h, and measured B cell viabil-
ity. As expected (Su and Rawlings, 2002), WT T1 B cells died   
rapidly after anti-Ig stimulation (Fig. 2 E), whereas WT T2/T3 
B cells were largely resistant to anti-IgM–induced cell death 
(Fig. 2 F). Interestingly, significantly more of the Gnaq/ T1 
(Fig. 2 E) and T2/T3 B cells (Fig. 2 F) survived the culture pe-
riod, regardless of whether the B cells were stimulated with 
anti-IgM or cultured in media alone. Thus, Gnaq/ B cells 
Figure 2.  Gq-deficient B cells exhibit a prosurvival phenotype in vitro. (A–C) WT or Gnaq/ splenic B cells were stimulated with 0–25 µg/ml 
anti-IgM F(ab)2 (A), 0–40 µg/ml anti-CD40 (B), or 0–10 µg/ml LPS (C) for 48 h and proliferative responses were measured by 3H-thymidine incorporation 
after a 5-h pulse. Results represent the mean ± SD of triplicate cultures. (D–F) Purified total splenic B cells (D), sort-purified B220+CD93+CD23 T1 B cells 
(E), or sort-purified B220+CD93+CD23+ T2/T3 B cells (F) were cultured in media alone or stimulated with 10–15 µg/ml anti-IgM F(ab)2 for 18–24 h. Viability 
was measured by staining with propidium iodide. Data are shown as the mean ± SD of triplicate cultures. P-values were determined using an unpaired 
Student’s t test. Data in all panels are representative of three independent experiments.JEM VOL. 207, August 2, 2010 
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Next, to address whether the Gnaq/ B cells are more fit 
to survive than WT B cells, we prepared mixed BM chimeras 
by transferring equivalent numbers of WT (CD45.1+) and 
Gnaq/ (CD45.2+) BM cells into lethally irradiated WT 
CD45.1+ recipient mice (Fig. 4 D) and determined the rela-
tive composition of the splenic B cells after reconstitution. 
We found that the ratio of Gnaq/ B cells to WT B cells was 
already significantly increased by 1 mo after reconstitution 
(Fig. 4 E). Furthermore, by 8 wk after reconstitution the ratio 
of Gnaq/ to WT B cells was 4:1, and within 6 mo the ratio 
was 19:1 in favor of the Gnaq/ B cells (Fig. 4 E). We found 
that the FOB and MZB compartments were both skewed   
in favor of the Gnaq/ B cells at 8 wk after reconstitution; 
however, the MZB cell compartment was more highly 
skewed than the FOB compartment toward the Gnaq/  
B cells (Fig. 4 F). Likewise, all of the transitional B cells in   
the spleen were already highly skewed toward the Gnaq/  
B cells by 8 wk after reconstitution (Fig. 4 F). Interestingly, 
the T1 MZB precursor population was almost entirely de-
rived from the Gnaq/ B cells within 8 wk after reconstitu-
tion (ratio of 20:1; Fig. 4 F). The skewing of the peripheral   
B cell compartments toward Gnaq/ B cells was not a result 
of changes in the output of B cell progenitors from the BM, 
as the ratio of Gnaq/ to WT immature B cells in the BM 
(fraction E) remained very close to 1:1 at 8 wk after reconsti-
tution (Fig. 4 F). However, the ratio of Gnaq/ to WT 
B220+CD93+IgM+CD23+  transitional  B  cells  in  the  BM 
(Lindsley et al., 2007) increased slightly (2.0) and the re-
circulating mature B cells in the BM were highly skewed   
toward the Gnaq/ genotype (10:1 ratio; Fig. 4 F).
Finally, to evaluate whether the increase in Gnaq/ B cells 
relative to WT B cells in the spleen of the mixed chimeric mice 
was the result of increased proliferation of the Gnaq/ B cells, 
we injected the 50:50 BM chimeras with 5-ethynyl-2- 
deoxyuridine (EdU) at 8 wk after reconstitution and then 
was a result of the presence of more MZB cells in the Gnaq/ 
spleens, we assessed phospho-Akt levels in CD43neg naive   
B cells and enriched populations of FOB and MZB cells. As 
expected, phospho-Akt levels were constitutively elevated in 
naive CD43neg Gnaq/ B cells and more rapidly reached 
peak levels after anti-IgM stimulation (Fig. 3 D). In contrast, 
the  phospho-Akt  levels  in  the  enriched  FOB  cells  were 
equivalent between the WT and Gnaq/ B cells both before 
and after anti-IgM stimulation (Fig. 3 D). However, phospho-
Akt levels were constitutively elevated in the Gnaq/ MZB 
cells relative to the WT MZB cells (Fig. 3 D). Furthermore, 
phospho-Akt levels increased to peak levels more rapidly   
and were sustained for extended periods of time after BCR 
stimulation in the Gnaq/ MZB cells (Fig. 3 D). Together, 
these data suggest that Akt activation after BCR engagement 
is specifically enhanced in Gnaq/ MZB cells.
Gnaq/ B cells outcompete WT B cells for access to splenic 
niches in vivo
Collectively, our data suggested that Gnaq/ B cells may 
survive better than WT B cells in vivo. To test this, we trans-
ferred equivalent numbers of splenic B cells from WT or 
Gnaq/ chimeras (CD45.2+) into intact congenic CD45.1+ 
WT hosts (Fig. 4 A). At various time points after transfer, we 
enumerated donor CD45.2+ B cells in the spleen by FACS. 
As shown in Fig. 4 (B and C), the percentages and numbers 
of donor Gnaq/ B cells recovered at 1 wk after transfer 
were significantly higher compared with those found in re-
cipients receiving WT B cells. At days 14 and 21 after transfer, 
very few of the transferred WT B cells could be found in the 
congenic hosts (Fig. 4 B). However, the transferred Gnaq/ 
B cells were easily detectable and present at 10-fold higher 
frequencies and numbers than the WT B cells (Fig. 4, B and C). 
Thus, the data suggested that Gnaq/ B cells survive longer 
in vivo than WT B cells.
Figure 3.  Gq-deficient B cells are hyperresponsive to BCR triggering. (A–D) Splenic B cells from Gnaq/ and WT chimeras were stimulated with 
anti-IgM F(ab)2 for 0–30 min. Protein lysates were prepared from negatively selected total B cells (A and D) or from enriched FOB and MZB cells (D) and 
then analyzed by Western blotting. Akt (p-Ser473), PLC2, and Erk were probed with phospho-specific Abs and protein-specific Abs. Li-COR quantitative 
densitometry was used to determine the fold changes in phospho-Akt (B) and phospho-PLC2 (C). The ratios of phospho-specific proteins versus total ERK 
or PLC2 were obtained and data were normalized to WT B cells at time 0 (set as 1). Data in all panels are representative of two independent experiments.1780 Gq suppresses B cell–mediated autoimmunity | Misra et al.
Figure 4.  Gq-deficient B cells have a competitive survival advantage over WT B cells in vivo. (A–C) Splenic B cells were purified from WT and 
Gnaq/ chimeras (CD45.2+) and transferred i.v. into CD45.1+ WT hosts (2.5 × 107 cells/host). (B) Spleen cells from recipient mice were harvested at 1–3 wk  
after transfer and analyzed by flow cytometry to identify donor B cells. Representative dot plots and the mean percentage ± SD of cells of donor origin are 
shown. (C) The number of donor B cells recovered per recipient spleen was determined and is shown as the mean ± SD (n = 3–5 mice/group/time point). 
Data are representative of two independent experiments. (D–G) Lethally irradiated CD45.1+ WT mice were reconstituted with a mixture of BM  
consisting of 50% Gnaq/ (CD45.2+) BM and 50% WT (CD45.1+) BM. (E) Splenic B cells were collected from the 50:50 BM chimeras and flow cytometry 
was used to identify WT and Gnaq/ B cells. Data are presented as the ratio of Gnaq/ to WT B cells (percentage of Gnaq/ B cells divided by percentage 
of WT B cells) at each time point and are shown as the mean ± SD from five mice per group. Data are representative of more than three independent 
experiments. (F) BM and spleen were collected from the 50:50 BM chimeras at 2 mo after reconstitution, and the ratio of Gnaq/ to WT B cells was  
determined as described in E. Splenic B cells were subdivided into total mature (B220+CD93), FOB (B220+CD21loCD23hi), MZB (B220+CD21hiCD23lo), T1 
(B220+CD93+CD23), T2/T3 (B220+CD93+CD23+), T1 MZB precursors (B220+CD93+IgMhiCD21hi), and T2/FOII MZB precursors (B220+CD93CD21hiCD23hi).  
B cells in the BM were subdivided into immature (fraction E) B cells (B220+CD93+IgM+), transitional (B220+CD93+IgMhiCD23+), and recirculating 
(B220hiIgM+IgD+). Data are shown as the mean ± SD of four to five mice/group. (G) 50:50 BM chimeras (2 mo after reconstitution) were injected with EdU 
twice over a 12-h period. Spleen cells were isolated at 18 h, stained with Abs to CD19 and CD45.2 and the EdU detection reagent, and then analyzed by 
flow cytometry. Representative FACS plots are shown and the percentage of B cells of each genotype that incorporated EdU is provided. Data shown are 
the mean ± SD of five mice. Data in D–G are representative of two independent experiments.JEM VOL. 207, August 2, 2010 
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B cells to WT B cells was 1.5 at 8 wk after reconstitution 
(Fig. 5 B), indicating that Gnaq/ B cells were already over-
represented in the blood at this time. The ratio of Gnaq/  
B cells to WT B cells in peripheral blood modestly increased 
over the next 3 wk in the chimeras that were treated with the 
isotype control Ab (Fig. 5 B), which is consistent with the 
gradual takeover by Gnaq/ B cells. However, the ratio of 
Gnaq/ B cells to WT B cells increased even more rapidly 
in the anti-BAFF–treated chimeras (Fig. 5 B).
Next, we determined the percentage (Fig. S3 B) and num-
ber (Fig. 5 C) of mature WT (CD45.1+) and Gnaq/ (CD45.2+) 
B cells present in the spleens of the mixed BM chimeras   
on day 21 after treatment. As expected, approximately three 
times more mature Gnaq/ B cells were recovered relative 
to WT B cells in the control Ab–treated chimeras (Fig. 5 C). 
After BAFF blockade, we observed a significant reduction in 
the number of total mature B cells, regardless of genotype 
(Fig. 5 C). However, although the number of WT B cells 
decreased by 23-fold after anti-BAFF treatment, the number 
of Gnaq/ B cells dropped by only 13.5-fold (Fig. 5 C). 
Furthermore, the ratio of splenic Gnaq/ B cells to WT B cells 
increased from 3.1 in the control Ab–treated chimeras to 5.0 
determined the proportion of WT and Gnaq/ B cells that 
proliferated in 18 h. As shown in Fig. 4 G, the percentage of 
replicating B cells was not significantly different between 
Gnaq/ and WT B chimeras. Together, these data argue that 
the Gnaq/ B cells are not overtly more proliferative than 
WT B cells but are able to efficiently outcompete WT B cells 
for access to or retention within peripheral survival niches.
Gnaq/ B cells are more resistant to BAFF withdrawal
Because Gnaq/ B cells quickly outcompete WT B cells in 
the spleen, we next tested whether the Gnaq/ B cells are 
less reliant on survival factors such as BAFF. We generated 
50:50 mixed BM chimeras by transferring equal amounts of 
CD45.1+ WT BM and CD45.2+ Gnaq/ BM to irradiated 
CD45.1 WT hosts. We treated the recipients with a neutral-
izing anti-BAFF or isotype control Ab 8 wk after reconstitu-
tion and then monitored WT and Gnaq/ B cells in the 
peripheral blood and spleen over the next 3 wk (Fig. 5 A). 
We determined the percentage of B cells in peripheral blood 
that were either Gq deficient or WT at each of the time 
points (Fig. S3 A) and then calculated the ratio of Gnaq/   
B cells to WT B cells. The ratio of peripheral blood Gnaq/ 
Figure 5.  Gnaq/ B cells are more resistant to 
BAFF neutralization in vivo and are more sensitive 
to BAFF stimulation in vitro. (A–D) 50:50 mixed BM 
chimeras were generated using Gnaq/ BM (CD45.2+) 
and WT (CD45.1+) BM. 8 wk after reconstitution, chimeric 
animals were injected i.p. with a blocking Ab to BAFF/
BLyS (clone 10F4) or an isotype control Ab. (B) Peripheral 
blood samples were collected from Ab-treated chimeric 
animals between 7 and 21 d and flow cytometry was 
used to identify the percentage of B cells that were of 
WT or Gnaq/ origin. Data are shown as the ratio 
(±SEM) of Gnaq/ to WT B cells (percentage of Gnaq/ 
B cells divided by percentage of WT B cells; n = 5–10 
mice). P-values were determined using an unpaired Stu-
dent’s t test. (C) Spleen cells from Ab-treated chimeras 
were isolated, enumerated, and analyzed by flow cytom-
etry at 21 d after treatment. The numbers of mature 
splenic B cells (B220+CD24lo) of WT and Gnaq/ origin 
were determined and are reported as the mean ± SD of 
five mice/group. The fold depletion caused by BAFF neu-
tralization is shown above the bar graphs. (D) The ratio of 
Gnaq/ to WT B cells in the spleen was calculated (per-
centage of Gnaq/ B cells divided by percentage of WT 
B cells) and is shown as the mean ± SD. P-values were 
determined using an unpaired Student’s t test. Data in  
A–D are representative of three independent experiments. 
(E) Splenic CD43neg naive B cells were isolated from 
Gnaq/ and WT chimeras and enriched for CD21lo FOB 
and CD21hi MZB cells. The total or enriched B cell subsets 
were cultured in BAFF-free media overnight. Live cells 
were recovered from the cultures and stimulated with 
recombinant BAFF for 0–10 min. Protein lysates were 
prepared and analyzed by Western blotting. Phospho-Akt 
(p-Ser473), total Akt, and phospho-S6 ribosomal protein 
were detected using phospho- and protein-specific Abs. 
Data in E is representative of two experiments.1782 Gq suppresses B cell–mediated autoimmunity | Misra et al.
Figure 6.  Gq-deficient B cells display an activated phenotype and are intrinsically prone to develop autoreactive specificities. (A and B) 50:50  
mixed BM chimeras were generated using Gnaq/ BM (CD45.2+) and WT (CD45.1+) BM. 11 wk after reconstitution, cells from BM, spleen, and lungs  
were harvested and B cells were analyzed by flow cytometry for expression of PNA and FAS. Representative FACs plots are shown (A) and the percentages 
of WT or Gnaq/ B cells expressing a GC phenotype (PNAhiFAS+) were determined (B). Data are shown as the mean ± SD of four to five mice per  
time point. P-values were determined using an unpaired Student’s t test. All data shown are representative of two independent experiments. (C) WT and 
Gnaq/ BM chimeras were generated and aged for 5 mo. Serum samples were collected monthly. The presence of ANAs (ANA reactivity) in the serum 
(diluted 1:100) was then determined by fluorescence microscopy using fixed HepG2 cells. The data are shown as the percentage of animals with detect-
able ANAs in the serum (n = 10 mice/group). (D) Serum samples were collected from female WT and Gnaq/ chimeras at 9 mo after reconstitution. Sam-
ples were evaluated for reactivity to dsDNA by ELISA. Data shown are the mean OD ± SD from a 1/200 dilution of the serum samples. n = 4–5 mice/group. 
P-values were determined using an unpaired t test. Data in panels C and D are representative of two or more independent experiments. (E–I) 50:50 mixed 
BM chimeras were made by reconstituting irradiated Igha hosts with 50% WT BM (Igha allotype) and 50% Gnaq/ BM (Ighb allotype; referred to as 
Gnaq/:WT chimeras) or with 50% WT BM (Igha allotype) plus 50% WT BM (Ighb allotype; referred to as WT:WT chimeras). (F and G) Peripheral blood 
from the WT:WT (F) and Gnaq/:WT (G) chimeras was analyzed by flow cytometry between 2 and 10 mo after reconstitution using allotype-specific Abs 
to identify the B cells of either WT or Gnaq/ origin. Data are shown as the mean percentage of B cells of the different genotypes ± SD. n = 10 mice/
group. (H) Serum, isolated from WT:WT and Gnaq/:WT chimeras at 5 mo after reconstitution, was incubated (1:100 dilution) with fixed HepG2 cells. 
ANA-reactive Abs were detected using allotype-specific Abs. Representative fluorescent images are shown. Bars, 50 µm. (I) The fluorescence signal de-
tected from each serum sample was determined and shown as the mean fluorescent signal ± SD (n = 9–10 mice/group). Data in E–I are representative of 
two independent experiments. P-values were determined using an unpaired Student’s t test.JEM VOL. 207, August 2, 2010 
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B cells from the same animal expressed PNAhiFas+ in spleen, 
lung, and BM (Fig. 6, A and B), suggesting that Gnaq/ B cells 
make up most of the GCs present in these mice. In support   
of this conclusion, we identified well defined B cell follicles in 
the lungs of Gq-deficient chimeras, and some of the B cells 
within these follicles expressed the GC marker GL7 (Fig. S4 B). 
As these structures are not found in the lungs of naive normal 
mice (Moyron-Quiroz et al., 2004), the data suggest that Gnaq/   
B cells are being activated by endogenous self-ligands.
Intrinsic defects in Gnaq/ B cells result  
in the development of autoreactive B cells
To address whether Gnaq/ B cells are self-reactive, we evalu-
ated whether serum Abs from WT and Gnaq/ chimeras were 
reactive in a standard anti-nuclear Ab (ANA) assay. As expected, 
none of the serum samples from WT chimeras exhibited ANA 
reactivity  at  any  time  point  after  reconstitution  (Fig.  6  C).   
In contrast, 20% of the serum samples from Gnaq/ chimeras 
were ANA reactive within 2 mo after reconstitution. By 5 mo 
after reconstitution, 100% of the serum samples from Gnaq/ 
chimeras were ANA+ (Fig. 6 C). Interestingly, we observed 
that some of the serum samples strongly stained the entire nu-
cleus,  whereas  others  exhibited  a  more  punctate  pattern  of 
staining (Fig. S4 C), suggesting that multiple auto-Ags can be 
recognized by Gnaq/ B cells. Indeed, we also identified sig-
nificantly higher levels of anti–double-stranded (ds) DNA reac-
tivity in some Gnaq/ chimera serum samples (Fig. 6 D).
To determine whether the development of autoreactive   
B cells in Gnaq/ chimeras is the result of an intrinsic defect 
in the Gnaq/ B cells, we lethally irradiated WT Igha allotype 
congenic mice and reconstituted them with 50% WT Igha 
BM and 50% Ighb Gnaq/ BM (Gnaq/:WT chimera) or 
with 50% WT Igha BM + 50% WT Ighb BM (WT:WT chi-
mera; Fig. 6 E). At various time points after reconstitution, we 
collected serum and peripheral blood cells. As expected, pe-
ripheral blood B cells from the WT:WT chimeras were evenly 
distributed, with 50% of the B cells expressing an Igha BCR 
and the other half expressing Ighb BCRs (Fig. 6 F). In contrast,   
in the Gnaq/:WT chimeras, the Ighb-expressing Gnaq/  
B cells outcompeted the Igha-expressing WT B cells and 
eventually became the dominant B cell population present   
in the peripheral blood (Fig. 6 G). We next evaluated the   
serum samples for ANA reactivity using allotypic-specific Abs 
to detect the ANAs. As expected, neither Igha nor Ighb Abs 
from the serum of WT:WT chimeras exhibited ANA reactiv-
ity (Fig. 6 H). However, analysis of serum from the Gnaq/:
WT chimeras, revealed that the Ighb Abs (derived from the 
Gnaq/ B cells) efficiently stained the nucleus of HepG2 cells 
(Fig. 6 H). In contrast, the Igha Abs (derived from the WT   
B cells present in the same host) did not stain HepG2 nuclei 
(Fig. 6 H). Indeed, ANA reactivity of the WT Igha Abs from 
the Gnaq/:WT chimeras did not rise above background and 
was equivalent to that observed for the Igha Abs from WT:WT 
chimeras (Fig. 6 I). This was not the result of a lack of Igha  
Ab in the Gnaq/:WT serum samples, as nonautoreactive 
Igha Abs were present at low, but still detectable, levels in   
in the anti-BAFF–treated chimeras (Fig. 5 D). This change in 
the ratio of splenic Gnaq/ B cells to WT B cells was not the 
result of an obvious difference in BAFFR expression levels 
between WT and Gnaq/ B cells (Fig. S3, C and D). Thus, 
Gnaq/ B cells are significantly more resistant to BAFF deple-
tion than their WT counterparts.
BAFF signaling in B cells is reported to stimulate PI3K 
and induce activation of the Akt signaling pathway (Patke et al., 
2006). Given the increase in constitutively phosphorylated 
Akt observed in the Gnaq/ B cells and the increased   
resistance of these B cells to BAFF depletion, we evaluated 
whether Gnaq/ B cells are more responsive to BAFF sig-
nals than their WT counterparts. We isolated splenic CD43neg 
naive B cells, FOB cells, and MZB cells from WT and Gnaq/ 
chimeras. We cultured the cells overnight in the absence of 
BAFF, purified the live cells, stimulated the BAFF-starved   
B cells with recombinant BAFF protein, and then monitored 
activation of the Akt signaling pathway by measuring phos-
phorylation of Akt and one of its downstream signaling targets, 
S6 ribosomal protein. As shown in Fig. 5 E, phospho-Akt was 
observed at higher levels in BAFF-starved Gnaq/ CD43neg 
B cells than in WT CD43neg B cells. After BAFF stimulation, 
phospho-Akt levels increased more rapidly in the Gnaq/  
B cells. This finding was recapitulated when either FOB or 
MZB cells were analyzed (Fig. 5 E) but was most striking in 
the Gnaq/ FOB cell subset (Fig. 5 E). Interestingly, although 
Gq deficiency amplified BAFF-dependent Akt activation in 
both FOB and MZB cell subsets, phosphorylation of S6 ribo-
somal protein was equivalent between BAFF-stimulated WT 
and Gnaq/ FOB cells (Fig. 5 E). However, phospho-S6 
levels were constitutively higher in Gnaq/ MZB cells than 
in WT B cells and were induced to higher levels in the 
Gnaq/ MZB cells after BAFF stimulation (Fig. 5 E). Together, 
these data indicate that the Akt prosurvival pathway is con-
stitutively more active in BAFF-deprived Gnaq/ B cells and   
that Gnaq/ B cells engage this pathway more efficiently than 
WT B cells after BAFF stimulation.
Gnaq/ B cells are spontaneously activated in vivo
Because Gnaq/ B cells are more resistant to BAFF depriva-
tion, we postulated that Gnaq/ B cells may survive peripheral 
tolerance checkpoints that normally eliminate B cells with self-
reactivity. If this were true, then Gnaq/ B cells might be acti-
vated and responding to self-antigens. To test this hypothesis, 
we made 50:50 mixed BM chimeras by reconstituting CD45.1+ 
WT recipients with an equal mixture of CD45.1+ WT BM and 
CD45.2+ Gnaq/ BM. We isolated cells from spleen, BM, and 
lung at 3 mo after reconstitution and used FACS to phenotypi-
cally characterize the B cells. Gnaq/ B cells from the mixed 
BM  chimeras  expressed  statistically  higher  levels  of  CD80, 
CD40, and MHC class II than the WT B cells isolated from the 
same animals (Fig. S4 A). Next, using peanut agglutinin (PNA) 
and FAS to identify B cells with a germinal center (GC) pheno-
type (PNAhiFas+), we found only a very small proportion of 
WT B cells with this phenotype in any tissue (Fig. 6, A and B). 
However, significantly higher proportions of the Gnaq/  1784 Gq suppresses B cell–mediated autoimmunity | Misra et al.
Gq suppresses the development of systemic autoimmunity
Given the propensity of Gnaq/ B cells to secrete autoreactive 
Abs, we predicted that Gnaq/ chimeras would develop auto-
immune disease. To test this, we determined whether immune 
complexes were present in the kidneys of WT and Gnaq/ 
the Gnaq/:WT chimera serum samples (Fig. S4 D). Together, 
the data indicate that the development of autoreactive B cells 
is dependent on the loss of Gq expression in B cells. Further-
more, the loss of Gq in other hematopoietic cells is not suffi-
cient to drive normal B cells to become autoreactive.
Figure 7.  Gq-deficient chimeras develop B cell–dependent systemic autoimmunity. (A and B) Arterial blood from WT and Gnaq/ BM chimeras (8 mo 
after reconstitution) was isolated and complete blood cell counts were performed. Mean red blood cell counts (A) and hemoglobin concentration (B) are reported. 
Data shown are the mean ± SD of four mice/group and are representative of two independent experiments. P-values were determined using an unpaired Student’s t 
test. (C) The diameters of ankle and wrist joints were measured in WT and Gnaq/ chimeras at 5 mo after reconstitution. Data are represented as the mean ± SD of 
8–10 mice/group. Similar results were seen in three experiments. P-values were determined using an unpaired Student’s t test. (D–K) Histological analysis (hema-
toxylin and eosin [H&E]) of knee and ankle joints from WT and Gnaq/ chimeras was performed at 5 mo after reconstitution. (D) Normal knee joint from a WT 
chimera showing femur (F) and Tibia (T). (E) Knee joint from a Gnaq/ chimera with focal soft tissue inflammation (arrow) adjacent to a joint space (S) where the 
synovial lining is disrupted. A higher power view (F) demonstrates a focus of mixed inflammatory cells (arrow) and necrosis of the overlying synovium. (G) The ar-
ticular surface of the distal femur of a Gnaq/ chimera is irregular, thinned, and covered by fibrous pannus (arrows). (H) Normal ankle joint from a WT chimera.  
(I) Ankle from a Gnaq/ chimera with marked inflammation of soft tissues accompanied by exostotic bone (arrows) and accumulation of fibrin within the joint space (S).  
(J) Bone from the foot of a Gnaq/ chimera with proliferative periostitis overlying an area of bone lysis represented as scalloping of the bone surface (arrows).  
(K) Higher power of bone from the foot shows multinucleated osteoclasts within resorptive foci (arrows). Images are from one representative animal out of 5–10 
mice/group. Bars: (D–J) 100 µm; (K) 20 µm. Two independent experiments were performed. (L) Survival of Gnaq/ and WT chimeras was tracked for 6 mo after BM 
reconstitution. Data are shown as the percentage of survival of each group (n = 10 mice/group). P-values were determined using the Wilcoxon test. Data are repre-
sentative of three independent experiments. (M) Gq-deficient and WT chimeras were treated with anti-CD20 (clone 18B12) or control Ab at 2 mo after reconstitu-
tion and survival was tracked over the next 11 mo. The experiment was performed once with 10 mice/group. P-values were determined using a Log-rank test.JEM VOL. 207, August 2, 2010 
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control  or  anti-CD20  Ab  (Fig.  7  M).  Gnaq/  chimeras 
treated with the control Ab had high rates of mortality, with 
60% of the chimeras dying within 10 mo of reconstitution 
(Fig. 7 M). In striking contrast, only 10% of the anti-CD20–
treated Gnaq/ chimeras died during the study (Fig. 7 M). 
Thus, Gq expression by B cells is necessary for normal pe-
ripheral B cell development and tolerance induction and also 
plays a role in preventing early onset mortality in mice.
DISCUSSION
It  is  estimated  that  >800  seven-transmembrane  GPCRs  are   
encoded in the mammalian genome. B lymphocytes, like other 
hematopoietic cells, express GPCRs, some of which play im-
portant roles in regulating B lymphocyte adhesion and traffick-
ing (Wettschureck et al., 2004). In this paper, we show that Gq 
regulates B cell repertoire selection by controlling B cell survival 
during transitional cell differentiation. Aberrant regulation at this 
point allows inappropriate survival of autoreactive B cells, ulti-
mately resulting in the development of autoimmune disease.
Gq is expressed in B lineage cells throughout develop-
ment (Wilkie et al., 1991). However, Gq appears to have   
little to no effect on the survival or expansion of BM B cell 
progenitors. Instead, Gq exerts its effects at the earliest T1 
stage of transitional B cell development and extends its influ-
ence to all transitional and mature B cells subsets. Interest-
ingly, the loss of Gq particularly favors the development of 
MZB-like cells. At least three precursors for the mature MZB 
cells have been identified: the T2 MZB precursor (Srivastava 
et al., 2005), the T1-MZB precursor (Carey et al., 2008), and 
the FOII precursor (Cariappa et al., 2007). Interestingly, only 
the  T1-MZB  precursor  population  was  expanded  in  the 
Gnaq/ chimeras and this population was the most highly 
skewed in favor of Gnaq/ B cells in the mixed BM chimeras. 
Therefore, we think it likely that the Gnaq/ MZB-like cells 
develop directly from the T1 MZB precursors.
The MZB compartment contains B cells that are posi-
tively selected from a subpopulation of proliferating T2 B cells 
(Meyer-Bahlburg et al., 2008) as well as potentially autoreac-
tive B cells that escape deletion at the T1 to T2 checkpoint 
(Thien et al., 2004). T1 B cells with low affinity for self-antigens 
normally up-regulate BAFFR, colonize the B cell niches of 
the spleen, and enter the mature B cell pool (Thien et al., 
2004). In contrast, B cells of intermediate affinity for self-antigen 
are excluded from the splenic niches and rapidly die (Cyster 
et al., 1994). However, when BAFF is readily available, the 
intermediate affinity autoreactive B cells are rescued and   
positively selected into the MZ compartment (Thien et al., 
2004). These results indicate that B cells with a higher affinity 
for self-antigen compete less effectively than the lower affin-
ity B cells for a limiting pool of BAFF. It is clear from our 
data that the Gnaq/ B cells can outcompete WT B cells under 
homeostatic conditions and that Gnaq/ B cells are less   
dependent on BAFF for survival than WT B cells. This would 
permit  relaxed  stringency  of  negative  selection  for  the 
Gnaq/ B cells and allow for the entry of potentially autore-
active cells into the mature MZB compartment. However, it 
chimeras. No Ab-containing immune complexes were detected 
in the WT kidney sections (Fig. S5, A–C). In contrast, IgG2a- 
and IgG2c-containing immune complexes were reproducibly 
observed in kidney sections from Gnaq/ chimeras (Fig. S5, 
D–F). However, despite immune complex deposition in the 
kidney, kidney function, as assessed by measuring protein   
concentration in the urine, was normal in the Gnaq/ chime-
ras (unpublished data). Histopathologic analysis of the kidneys 
from Gnaq/ chimeras showed mild to moderate mesangiolysis 
(thrombotic microangiopathy) with splitting of the basement 
membranes in the glomeruli and increased mesangial matrix 
within the glomeruli (Fig. S5, G–J). Although this pathology 
is atypical for the most common forms of immune complex–
mediated disease, thrombotic microangiopathy can be a mani-
festation of disease in Lupus patients with anti-coagulant, anti- 
phospholipid, or anti-endothelial Abs (Tektonidou, 2009).
In addition to changes in the kidney, the chimeras exhib-
ited other symptoms consistent with autoimmune disease. 
For example, we noted that the BM from the older Gnaq/ 
chimeras appeared to have reduced numbers of RBCs. To test   
whether the Gnaq/ chimeras develop anemia, we performed 
complete  blood  counts  on  arterial  blood  from  WT  and 
Gnaq/  chimeras.  We  found  that  the  number  of  RBCs   
and the concentration of hemoglobin were significantly   
reduced in the Gnaq/ chimeras (Fig. 7, A and B). These 
symptoms are consistent with a diagnosis of autoimmune he-
molytic anemia as a result of the presence of anti-RBC Abs, 
or they could also be a consequence of the autoimmune kid-
ney thrombotic microangiopathy (Tektonidou, 2009).
We also monitored joint swelling in WT and Gnaq/ 
chimeras, as we observed that many of the older Gnaq/ 
chimeras were less mobile than their WT counterparts. Sig-
nificant differences in the size of the joints of Gnaq/ chi-
meras was observed within 3.5 mo of reconstitution and   
the penetrance of disease in the Gnaq/ chimeras was 100% 
(unpublished data). By 5 mo after reconstitution, significant 
swelling was observed in both ankle and wrist joints of Gnaq/ 
chimeras compared with the WT chimeras (Fig. 7 C). Histo-
logical analysis of knees, ankles, and portions of feet from 
Gnaq/ chimeras revealed a variety of arthritic changes includ-
ing chronic/active areas of inflammation within the joints, 
evidence of synovitis and bone resorption, exostotic bone devel-
opment, and osteolytic activity (Fig. 7, D–K).
Collectively, our data suggest that Gnaq/ chimeras de-
velop systemic autoimmune disease with multiorgan involve-
ment. Consistent with this, we noted a significant difference 
between the survival of Gnaq/ and WT chimeras with up 
to 50% of the Gnaq/ chimeras dying within 6 mo of recon-
stitution (Fig. 7 L). To test whether the loss of Gq in B cells 
is  responsible  for  the  increased  mortality  observed  in  the 
Gnaq/ chimeras, we depleted B cells in WT and Gnaq/ 
chimeras at 8 wk after reconstitution using anti–mouse CD20 
(Hamel et al., 2008; Yu et al., 2008). We then monitored 
survival in the anti-CD20 and control Ab–treated chimeras 
over the next several months. As expected, mortality rates 
were very low in WT chimeras treated with a single dose of 1786 Gq suppresses B cell–mediated autoimmunity | Misra et al.
increased active PI3K, resulting in the augmented phosphory-
lation of Akt, activation of the mTOR pathway, and an in-
crease in the MZB compartment. Our experiments indicate 
that the increased Akt activity observed after BCR engagement 
is most pronounced in the MZ-like B cells found in Gnaq/ 
chimeras. This selective enhanced engagement of the pro-
survival Akt pathway may explain why these MZB cells are 
present in larger numbers in the Gnaq/ chimeras. Interest-
ingly, activation of Akt was very similar in the anti-IgM–
stimulated FOB cells from Gnaq/ and WT chimeras. This 
result was initially unexpected given that both MZB and 
FOB cell subsets are expanded in the Gnaq/ mice. However, 
Akt  is  also  constitutively  more  activated  in  BAFF-deprived 
Gnaq/ B cells and is increased more strongly after BAFF 
stimulation. This enhanced response to BAFF was observed 
in both the FOB and MZB cells from Gnaq/ chimeras. 
Furthermore, BAFF-induced phosphorylation of S6, a down-
stream target of the Akt–mTOR pathway, was evident in both 
the MZB and FOB subsets, although it was most affected in the 
Gnaq/ MZB cells. Collectively, these data suggest that Gq 
deficiency confers both FOB and MZB cells with an enhanced 
ability to activate the PI3K–Akt pathway.
Although we have made progress in identifying the pro-
survival signaling pathway that is normally suppressed by Gq, 
we do not yet know which GPCR or ligand mediates this 
dampening signal in peripheral B cells. Our preliminary tran-
scriptome analysis indicated that >100 different GPCRs, in-
cluding chemokine receptors, are expressed by mature B cells. 
Our data suggest that B cell chemotaxis to CXCR4, CXCR5, 
Edg1, and CCR7 ligands is not abrogated by the loss of Gq. 
Although these data do not exclude the possibility that che-
mokine receptors play a separate Gq-dependent role in regu-
lating B cell survival, it is equally likely that one of the many 
non-chemokine receptor GPCRs expressed by B cells regu-
lates B cell survival. Unfortunately, surprisingly little is known 
regarding the role for these other GPCRs in B cells and more 
work will be needed to evaluate their potential roles in B cell 
development and selection.
The autoimmune disease that develops in Gnaq/ chimeras 
is similar, but not identical, to the disease that develops in BAFF 
Tg mice (Mackay et al., 1999). For example, both strains of mice 
have increased numbers of MZB cells, develop auto-Abs, and 
exhibit signs of lupus-like disease. However, kidney failure did 
not occur in Gnaq/ chimeras, despite evidence of immune 
complex deposition and mesangiolysis. Instead, the Gnaq/ 
chimeras develop arthritis and become anemic. Furthermore, 
the Gnaq/ chimeras develop inflammatory lesions and ectopic 
lymphoid tissues in multiple organs, including the lung. Given 
the  speed  with  which  autoimmune  disease  manifests  in  the 
Gnaq/ chimeras and the number of affected tissues, we believe 
that the animals suffer from a widespread autoimmune syndrome 
that affects multiple organ systems and likely involves autoreac-
tive B cells of different specificities. Importantly, the increased 
mortality observed in Gnaq/ chimeras is dependent on B cells, 
as a single round of B cell depletion significantly delayed the   
onset of morbidity and mortality. Although we do not yet know 
is important to note that the T1 compartment, which is initially 
BAFF unresponsive, is also substantially expanded in the Gnaq/ 
chimeras. Thus, either the loss of Gq affects more than just 
BAFF responsiveness or a proportion of the T1 cells can become 
BAFF responsive as they transit this developmental window. 
Regardless, our combined data strongly imply that loss of Gq 
facilitates the inappropriate survival of B cells in the periphery.
The data presented in this paper suggests that Gq is an im-
portant regulator of B cell homeostasis and survival. Although 
the neuronal defects in Gnaq/ mice make it impractical for   
us  to  monitor  the  long-term  development  of  clinical  auto-
immunity without generating BM chimeras, B cell homeostasis 
was identical in the Gnaq/ mice and the Gnaq/ chimeras. 
Therefore, our results are not an aberrant manifestation of irra-
diation and reconstitution but are a result of the loss of Gq spe-
cifically in hematopoietic cells. In addition, our data strongly 
argue that the Gnaq/ B cells are intrinsically defective and are 
more resistant than the WT B cells to cell death–inducing signals 
such as BAFF withdrawal or strong BCR signals. Although   
we do not yet know all the mechanistic details surrounding   
Gq-mediated suppression of B cell survival, we do know that 
unstimulated and BCR- or BAFF-activated Gnaq/ B cells 
have higher levels of active Akt as measured by phosphorylation 
of Ser473, a phosphorylation site which is under PI3K control. 
Prior work studying fibroblast cell lines (Bommakanti et al., 
2000; Ballou et al., 2003) and cardiomyocytes (Howes et al., 
2003) showed that Gq normally represses Akt activation. Fur-
thermore, overexpression of Gq in cardiomyocytes leads to car-
diac hypertrophy as well as cardiomyocyte apoptosis (Adams   
et al., 1998). Based on these data, it is speculated that low-level 
Gq activity may lead to PI3K-dependent Akt activation and 
cell survival, whereas high or sustained Gq activity results in   
PI3K/Akt repression and cell death (Hubbard and Hepler, 2006).
Although the active GTP-bound form of Gq interacts 
with different signaling partners, including PLC- and Btk 
(Hubbard and Hepler, 2006), published data indicate that   
Gq mediates its pro-apoptotic effect in myocytes by bind-
ing to p110 and suppressing the production of PIP3 by 
PI3K (Bommakanti et al., 2000; Ballou et al., 2003). This   
Gq-dependent inhibition of PI3K activity leads to reductions 
in Akt activation and suppression of the prosurvival mTOR 
pathway (Manning and Cantley, 2007). Interestingly, expres-
sion of activated p110 in B lymphocytes is sufficient to ensure 
survival of the mature B cell population, even when the BCR 
has been deleted (Srinivasan et al., 2009). Furthermore, deletion 
of PTEN, an inhibitor of PI3K, also promotes mature B cell 
survival (Srinivasan et al., 2009) and can rescue autoreactive 
B cells from anergy (Browne et al., 2009). Interestingly, the 
autoreactive prone MZB cell compartment is also expanded 
in mice expressing activated p110 or lacking PTEN (Anzelon 
et al., 2003; Srinivasan et al., 2009). Finally, B cells isolated 
from multiple models of autoimmunity are reported to ex-
press elevated levels of phospho-Akt (Wu and Mohan, 2009), 
and perturbations in the PI3K/Akt axis can lead to the devel-
opment of autoimmunity (Wu and Mohan, 2009). Based on 
these data, we speculate that the loss of Gq in B cells leads to JEM VOL. 207, August 2, 2010 
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anti-BAFFR-AF647, and CD45.2-APC-AF750 were produced by eBioscience, 
and IA/IE Pacific Blue and CD80-AF647 were obtained from BioLegend. All 
other Abs were purchased from BD. To analyze in vivo cell proliferation, chime-
ras were injected i.p. twice with the nucleic acid homologue EdU (Invitrogen)   
18 h before harvest. Splenocytes were then stained with Abs to CD19 and CD45.2, 
fixed with 1% neutral buffered formalin, permeabilized with saponin-based buffer, 
and incubated with the manufacturer-provided Pacific blue–conjugated EdU   
detection  agent.  Flow  cytometry  data  were  collected  using  FACSCalibur,   
Canto II, or LSR II instruments (BD) from the University of Rochester Flow 
Cytometry Core and were analyzed using FlowJo (Tree Star, Inc.).
Chemotaxis assays. Spleen cells from 50:50 mixed BM chimeras were isolated 
and stained with Abs to B220 and CD45.2 to identify WT (CD45.2neg) and 
Gnaq/ (CD45.2+) B cells. 3 × 105 total spleen cells were added to the top well 
of a transwell with a 5-µm pore size polycarbonate filter (Costar), and the indi-
cated amount of chemokine was added to the bottom well. Cells were recovered 
from the bottom well 2 h later, fixed, and then analyzed and counted on a flow 
cytometer to determine the number of B cells of each genotype that migrated to 
the bottom of the transwell. Data are reported as the chemotaxis index, which 
represents the fold change in the number of cells that migrated in response to the 
chemokine versus the number of cells that spontaneously migrated in the ab-
sence of chemokine. S1P was purchased from Avanti Polar Lipids and CXCL12, 
CXCL13, and CCL19 were purchased from R&D Systems.
In vivo B cell migration assay. B cells were purified from the spleens of 
CD45.2+ Gnaq/ and CD45.1+ WT chimeras by negative selection (>90% 
purity) using Abs to CD3, CD11b, and GR1 (MACS; Miltenyi Biotec). WT 
B cells were incubated at room temperature for 15 min in a solution of 80 µg/
ml biotin in PBS. Gnaq/ B cells were incubated at room temperature in PBS 
only. Cells were washed three times in PBS, resuspended in FACs buffer, and 
counted. The cells were mixed at a 1:1 ratio and the volume was adjusted to   
5 × 107 cells/ml. CD45.1+ recipient B6 mice (n = 4 mice) were then injected 
i.v. with the cell mixture (107 cells/recipient). Spleens from the recipient mice 
were harvested 18 h later and frozen sections were prepared. Sections were 
stained with PE-labeled anti-CD45.2 (to detect transferred Gnaq/ B cells) 
and a rat anti–mouse Ab to MOMA-1 (to identify the MZ). Sections were 
washed and then stained with SA-488 to detect transferred biotinylated WT   
B cells and an Alexa Fluor 647–labeled anti–rat Ab to detect the MOMA-1+ 
cells. Slides were viewed on a fluorescent microscope (Axio Observer.Z1; Carl 
Zeiss, Inc.) using a 10× objective (for 100× total magnification). Images were 
collected using AxioVision 4.5 software and converted into TIFFs.
B cell purification and in vitro proliferation and survival assays. Total   
B cells were purified by either positive (CD19+) or negative (CD3, CD4, CD8, 
CD43, CD11b, and CD11c negative) selection by MACS (Miltenyi Biotec).   
T1 and T2/T3 B cells were sort purified using a FACSAria sorter in the University 
of Rochester Flow Cytometry Core. Purity of the B cells was >90% in all ex-
periments. To measure proliferation, purified B cells (5 × 105/ml) were cultured 
in complete media for 2 d with 0–25 µg/ml of polyclonal goat anti–mouse anti-
IgM F(ab)2 (SouthernBiotech), 0–40 µg/ml of monoclonal rat anti–mouse 
CD40 (clone 1C10), or 0–10 µg/ml LPS (Escherichia coli 055:B5) followed by   
the addition of 1 µCi 3H-thymidine for 5 h. Thymidine incorporation was   
measured using a scintillation counter. For in vitro survival experiments, 106  
B cells/ml were cultured in media alone or were stimulated with 10–15 µg/ml 
of anti-IgM F(ab)2. Cells from the cultures were collected at 18–24 h and 
stained with propidium iodide to determine the percentage of live cells.
B cell transfers. Splenic B cells from WT and Gnaq/ chimeras (both CD45.2+) 
were purified by positive selection using MACS. 2.5 × 107 donor B cells were 
transferred i.v. into individual CD45.1+ hosts. Spleens from host mice were iso-
lated at 7, 14, and 21 d after transfer and the percentage and total number of trans-
ferred donor B cells were determined using flow cytometry.
Western blot analysis. Total naive B cells were purified (negative selection 
with biotinylated CD4, CD8, CD11c, and F4/80 Abs and SA microbeads or 
anti-CD43 beads; Miltenyi Biotec). CD43neg B cells were further separated 
whether Gq deficiency in B cells alone is sufficient to induce 
autoimmune disease, we do know that the loss of Gq specifi-
cally within B lineage cells is required for the development and 
survival of the autoreactive B cells. Together, our results indicate 
that the loss of Gq in other hematopoietic lineage cells, includ-
ing T cells, is not sufficient to drive the selection of normal   
B cells into the autoimmune repertoire.
Although Gnaq/ T cells are not sufficient to induce   
B cell autoreactivity, we cannot exclude the possibility that 
Gnaq/ T cells contribute to the disease. Indeed, the presence 
of GCs containing Gnaq/ B cells in the spleen, lung, LNs, 
and BM suggests that autoantigen-specific T cells are present 
and able to drive the GC reaction. Interestingly, a recent pub-
lication reported that Gq regulates TCR signaling (Ngai et al., 
2008). Preliminary unpublished experiments from our group 
indicate that Gnaq/ T cells outcompete normal T cells in the 
thymus of mixed BM chimeras. The competitive advantage   
of Gnaq/ T cells is observed at the double-negative stage of 
thymocyte development and persists throughout thymic and 
peripheral T cell development. However, the Gnaq/ T cells 
found in the LNs and spleen of the mixed chimeras are not 
constitutively activated as measured by expression levels of 
CD44, CD62L, or CD25. Thus, although Gq plays a role in 
T cell development, it is still not clear whether the loss of Gq 
expression on T cells will be necessary for the initiation of the 
autoimmune disorders observed in the Gnaq/ chimeras.
In conclusion, our work illustrates a critical intrinsic role 
for Gq in the maintenance of peripheral B cell immunological 
tolerance and shows that deficiencies in Gq expression contrib-
ute to the development of autoimmune disease. These data 
also provide the first demonstration that the survival and selec-
tion of B cells into the mature B cell repertoire is not only de-
pendent on NF-B activation in response to BCR and BAFFR 
engagement but is also controlled by G protein signals.
MATERIALS AND METHODS
Mice, BM chimeras, and in vivo Ab treatments. All experimental proce-
dures involving mice were approved by the Trudeau Institute Institutional   
Animal Care and Use Committee (IACUC) and the University of Rochester 
Committee on Animal Resources. C57BL/6J (B6), Gnaq/ (n > 5 backcross to 
C57BL/6J), CD45.1+ congenic B6, and B6.Cg-Igha Thy1a Ptrpca Pep3b/Boy 
(Igha) mice were bred in the University of Rochester or Trudeau Institute ani-
mal facilities. BM chimeras were generated by irradiating recipient mice with a 
split dose of 950 Rads from a 137Cs irradiator and then reconstituting the recipi-
ents with 1–2.5 × 106 BM cells from B6 or Gnaq/ donors. In some experi-
ments, CD45.1+ recipients were reconstituted with a mixture of 50% WT and 
50% Gnaq/ BM (50:50 chimeras). In other experiments, BAFF was depleted 
by injecting 50:50 BM chimeras i.p. with 250 µg of anti–mouse BAFF/BLyS 
(clone 10F4; Human Genome Sciences) or control hamster IgG (BioExpress) in 
PBS 1 time at 8 wk after reconstitution. CD20+ B cells were depleted by inject-
ing Gnaq/ and WT chimeras i.p. with 200 µg of mouse anti–mouse CD20 
(clone 18B12 IgG2a; Hamel et al., 2008) or with an isotype control Ab (clone 
2B8) one time at 9 wk after reconstitution. B cell–depleted and nondepleted 
chimeras were monitored for health and survival. Mice that appeared hunched 
with ruffled fur and/or had difficulty moving were euthanized in accordance 
with IACUC guidelines.
Flow cytometry and EdU assays. B220 APC-AF750 and CD23-APC were 
obtained from Invitrogen. SA–Pacific orange, SA-APC-AF750, and 5-AF488 
were  purchased  from  Invitrogen.  CD19  Pacific  blue,  CD93  biotin,   1788 Gq suppresses B cell–mediated autoimmunity | Misra et al.
a board-certified veterinary pathologist who was blinded to the experimental 
design. Images were collected using a microscope (Eclipse 80i; Nikon) with Plan 
Fluro 10×/0.30, Plan Fluro 20×/0.50, and Plan Fluro 60×/0.85 objectives.   
Images were recorded with a Digital Sight D5-5M camera using NIS Elements 
Acquisition Software (Nikon). Postimage processing was performed with NIS 
Elements for total picture contrast, balance, and color. All changes were made 
across the entire image and no spot changes were performed.
Immunofluorescence. Spleens from WT or Gnaq/ chimeras were har-
vested in OCT buffer (Tissue-Tek), snap frozen in LN2, sectioned (5 µm) on 
a cryostat, and then stained with anti-B220 Alexa Fluor 488, anti-CD21 Alexa 
Fluor 594, and anti-CD90.2 biotin followed by SA–Alexa Fluor 350. Slides 
were mounted in PolyMount fluorescent mounting media and viewed on an 
Axio Observer.Z1 fluorescent microscope at 100× (10× objective lens) using 
AxioVision 4.5 software. Images were converted to TIFFs and postprocessing 
imaging was performed in Canvas. Minor adjustments to brightness were 
performed equally across the whole image.
Online supplemental material. Fig. S1 shows FACS analysis of WT and 
Gq-deficient B cell development in BM and spleen. Fig. S2 shows that 
BCR ligation of Gq-deficient B cells leads to elevated tyrosine and serine phos-
phorylation of proteins. Fig. S3 shows that increased resistance of Gq-deficient 
B cells to BAFF blockade is not a result of altered BAFFR expression. Fig. S4 
shows that Gq-deficient B cells are activated and display autoreactive specifici-
ties. Fig. S5 shows that Gq-deficient chimeras develop immune complexes in 
the kidney and exhibit signs of kidney damage. Online supplemental material is 
available at http://www.jem.org/cgi/content/full/jem.20092735/DC1.
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